M. Yamamoto et al., Hippocampal level of neural specific adenylyl cyclase type I is decreased in Alzheimer's disease, BBA-MOL BAS, 1535(1), 2000, pp. 60-68
Citations number
35
Categorie Soggetti
Medical Research General Topics
Journal title
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
Previous studies reported disruption of adenylyl cyclase (AC)-cyclic AMP (c
AMP) signal transduction in brain of Alzheimer's disease (AD). We also demo
nstrated that basal and stimulated AC activities in the presence of calcium
and calmodulin (Ca2+/CaM) were significantly decreased in AD parietal cort
ex. In the present study, we examined the amounts of Ca2+/CaM-sensitive typ
es I and VIII AC, and Ca2+/CaM-insensitive type VII AC in the postmortem hi
ppocampi from AD patients and age-matched controls using immunoblotting. Th
e specificities of the anti-type VII and VIII AC antibodies were confirmed
by preabsorption with their specific blocking peptides. We observed a signi
ficant decrease in the level of type I AC and a tendency to decrease in the
level of type VIII AC in AD hippocampus. On the other hand, the level of t
ype VII AC showed no alteration between AD and controls. A body of evidence
from the studies with invertebrates and vertebrates suggests that types I
and VIII AC may play an essential role in learning and memory. Our finding
thus firstly demonstrated that a specific disruption of the Ca2+/CaM-sensit
ive AC isoforms is likely involved in the pathophysiology in AD hippocampus
. (C) 2000 Elsevier Science B.V. All rights reserved.